ArticleMolecular diversity2024

Repurposing the in-house generated Alzheimer's disease targeting molecules through computational and preliminary in-vitro studies for the management of SARS-coronavirus-2.

Gourav Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.